Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hector J Nunez"'
Autor:
Dagmar F Hernandez-Suarez, Kyle Melin, Frances Marin-Maldonado, Hector J Nunez, Ariel F Gonzalez, Lorena Gonzalez-Sepulveda, Sona Rivas-Tumanyan, Hetanshi Naik, Gualberto Ruaño, Stuart A Scott, Jorge Duconge
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Introduction Minority populations in the USA are disproportionately affected by cardiovascular conditions. Reduced responsiveness to clopidogrel among carriers of CYP2C19 variants has been reported in patients with either coronary artery disease (CAD
Externí odkaz:
https://doaj.org/article/a25cc988e2f8412da95b6ee78b586984
Autor:
Orlando Arce, Stuart A. Scott, Hector J Nunez, Gualberto Ruaño, Laura Ileana Fernández-Morales, Pablo A. González, Jorge Duconge, Marines Rosario, Andrés López-Reyes, Ednalise Santiago, Frances Marin-Maldonado, Jessicca Y. Renta, Luis Antonio Vélez-Figueroa, Dagmar F. Hernandez-Suarez, Mariangeli Moneró, Kyle Melin
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 6, Pp 2254-2266 (2021)
Clinical and Translational Science, Vol 14, Iss 6, Pp 2254-2266 (2021)
This multicenter clinical study was aimed at conducting a targeted pharmacogenomic association analysis of residual on‐clopidogrel platelet reactivity in 474 Caribbean Hispanic patients. Platelet reactivity was measured using the VerifyNow P2Y12 as
Autor:
Dagmar F Hernandez-Suarez, Kyle Melin, Lorena Gonzalez-Sepulveda, Gualberto Ruaño, Stuart A Scott, Jorge Duconge, Hector J Nuñez-Medina, Mariangeli Monero, Lorna M Torres, Enrique Leal, Ángel M Mayor, Jessicca Y Renta, Edgardo R González-García, Ariel González
Publikováno v:
BMJ Open, Vol 14, Iss 9 (2024)
Objectives To assess whether genotype-guided selection of oral antiplatelet drugs using a clinical decision support (CDS) algorithm reduces the rate of major adverse cardiovascular and cerebrovascular events (MACCEs) among Caribbean Hispanic patients
Externí odkaz:
https://doaj.org/article/7d3cc16172674513a3d950386d0a0bea
Autor:
Stuart A. Scott, Frances Marin-Maldonado, Dagmar F. Hernandez-Suarez, Gualberto Ruaño, Hetanshi Naik, Sona Rivas-Tumanyan, Kyle Melin, Jorge Duconge, Lorena González-Sepúlveda, Hector J Nunez, Ariel F. Gonzalez
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 8 (2020)
BMJ Open, Vol 10, Iss 8 (2020)
IntroductionMinority populations in the USA are disproportionately affected by cardiovascular conditions. Reduced responsiveness to clopidogrel among carriers ofCYP2C19variants has been reported in patients with either coronary artery disease (CAD) o